動物医療向けモノクローナル抗体の世界市場レポート 2025年

動物医療向けモノクローナル抗体の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR15.0％で16億1,000万米ドルに成長すると予想されます。予測期間の成長は、ペット人口の増加、ペット支出の増加、犬アトピー性皮膚炎の有病率の増加、高度獣医ヘルスケアに対する需要の増加、動物衛生の重要性の高まりに起因しています。予測期間の主な動向としては、バイオテクノロジーと研究の進歩、遺伝子工学の進歩、革新的治療、抗体ベースの治療薬の進歩、抗体工学の技術的進歩などが挙げられます。

動物の疾病発生率の増加は、動物医療向けモノクローナル抗体市場の成長を促進すると予測されています。このような疾病率の上昇は、感染症のリスクを高める農業慣行の激化や、マダニや蚊などの疾病媒介動物の範囲を広げる気候変動に起因しています。モノクローナル抗体は、病原体や疾病プロセスに関与するタンパク質を特異的に標的とするため、動物の疾病治療に非常に有効であり、正確で効果的な治療を提供します。例えば、GOV.UKが2024年6月に発表したレポートによると、2023年4月～2024年3月までに結核が原因で殺処分された動物の数は、イングランドでは5％増の21,298頭、ウェールズでは17％増の11,197頭でした。このような動物疾病事例の増加が、動物医療向けモノクローナル抗体市場の成長に寄与しています。

動物医療向けモノクローナル抗体市場の主要企業は、動物の慢性疼痛や炎症などの症状に対処するため、抗NGFモノクローナル抗体治療などの高度な治療ソリューションを開発しています。抗NGFモノクローナル抗体治療は、神経成長因子（NGF）を標的とし阻害することで、慢性疼痛状態の動物の痛みや炎症を軽減します。例えば、2023年5月、米国の動物用医薬品会社であるZoetisは、犬の変形性関節症（OA）に伴う疼痛を管理する初のモノクローナル抗体治療薬であるLibrela（bedinvetmab注射剤）のFDA承認を取得しました。Librelaは月1回の注射で投与され、NGFを標的とすることで痛みの信号が脳に到達するのをブロックし、痛みを緩和します。さらに、Zoetisは、1歳以上の犬のアレルギー性痒みと炎症を管理する初のチュアブル薬であるApoquel Chewableを発売しました。Librelaは獣医学的疼痛管理における大きな進歩であり、犬の慢性疼痛治療に新たなアプローチを提供するものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の動物医療向けモノクローナル抗体市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の動物医療向けモノクローナル抗体市場：成長率分析
• 世界の動物医療向けモノクローナル抗体市場の実績：規模と成長、2019～2024年
• 世界の動物医療向けモノクローナル抗体市場の予測：規模と成長、2024～2029年、2034年
• 世界の動物医療向けモノクローナル抗体総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の動物医療向けモノクローナル抗体市場：動物の種類別、実績と予測、2019～2024年、2024～2029年、2034年
• 犬
• その他
• 世界の動物医療向けモノクローナル抗体市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 皮膚疾患
• 疼痛
• その他
• 世界の動物医療向けモノクローナル抗体市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 動物病院
• その他
• 世界の動物医療向けモノクローナル抗体市場：犬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 犬の感染症
• 犬のがん治療
• 犬の自己免疫疾患
• 犬のアレルギー
• 世界の動物医療向けモノクローナル抗体市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 猫
• 馬
• 牛
• 豚
• 家禽
• 水生動物
• 小型哺乳類

第7章 地域別・国別分析

• 世界の動物医療向けモノクローナル抗体市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の動物医療向けモノクローナル抗体市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 動物医療向けモノクローナル抗体市場：競合情勢
• 動物医療向けモノクローナル抗体市場：企業プロファイル
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc（GSK）Overview, Products and Services, Strategy and Financial Analysis
  • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Regeneron Pharmaceuticals Inc.
• Zoetis Inc.
• MSD Animal Health
• Elanco Animal Health Incorporated
• Bio-Rad Laboratories Inc.
• Eli Lilly and Company
• GenScript Biotech Corporation
• Abcam plc
• Heska Corporation
• Neogen Corporation
• iNova Pharmaceuticals
• Ceva Sante Animale S.A.
• Biogenesis Bago S.A.
• TransGen Biotech Co. Ltd.
• AbCellera Biologics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 動物医療向けモノクローナル抗体市場2029：新たな機会を提供する国
• 動物医療向けモノクローナル抗体市場2029：新たな機会を提供するセグメント
• 動物医療向けモノクローナル抗体市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Monoclonal antibodies in veterinary health are engineered proteins designed to target and neutralize specific pathogens or toxins in animals, assisting in the diagnosis and treatment of various diseases. They are produced by cloning a single type of immune cell to generate identical antibodies that specifically bind to their target.

Monoclonal antibodies in veterinary health are primarily used for dogs, although they can also be used for other animals. Monoclonal antibodies are applied in fields such as dermatology and pain management, with end users including veterinary hospitals and other related facilities.

The monoclonal antibodies in veterinary health market research report is one of a series of new reports from The Business Research Company that provides monoclonal antibodies in veterinary health market statistics, including monoclonal antibodies in veterinary health industry global market size, regional shares, competitors with a monoclonal antibodies in veterinary health market share, detailed monoclonal antibodies in veterinary health market segments, market trends and opportunities, and any further data you may need to thrive in the monoclonal antibodies in veterinary health industry. This monoclonal antibodies in veterinary health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The monoclonal antibodies in veterinary health market size has grown rapidly in recent years. It will grow from $0.8 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to an increase in pet ownership worldwide, the prevalence of chronic diseases in animals, an increase in the number of pet adoption rates, and increased health concerns among pet owners.

The monoclonal antibodies in veterinary health market size is expected to see rapid growth in the next few years. It will grow to $1.61 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to the increasing pet population, rising pet expenditure, growing prevalence of canine atopic dermatitis, increasing demand for advanced veterinary healthcare, and rising importance of animal health. Major trends in the forecast period include advancements in biotechnology and research, genetic engineering advancements, innovative treatments, advancements in antibody-based therapeutics, and technological advancements in antibody engineering.

The increasing incidence of animal diseases is anticipated to drive the growth of the monoclonal antibodies in veterinary health market. These rising disease rates are attributed to intensified farming practices, which heighten the risk of infectious diseases, and climate change, which broadens the range of disease vectors such as ticks and mosquitoes. Monoclonal antibodies are highly effective for treating animal diseases because they specifically target pathogens or proteins involved in disease processes, offering precise and effective treatments. For example, a June 2024 report from GOV.UK noted that from April 2023 to March 2024, the number of animals slaughtered due to tuberculosis (TB) incidents increased by 5% in England to 21,298, and by 17% in Wales to 11,197. This rise in animal disease cases is fueling the growth of the monoclonal antibodies market in veterinary health.

Leading companies in the monoclonal antibodies in veterinary health market are developing advanced therapeutic solutions, such as anti-NGF monoclonal antibody treatments, to address conditions such as chronic pain and inflammation in animals. Anti-NGF monoclonal antibody treatment targets and inhibits nerve growth factor (NGF), reducing pain and inflammation in animals with chronic pain conditions. For instance, in May 2023, Zoetis, a US-based animal health company, received FDA approval for Librela (bedinvetmab injection), the first monoclonal antibody treatment for managing pain associated with osteoarthritis (OA) in dogs. Librela is administered as a monthly injection and works by targeting NGF to block pain signals from reaching the brain, thereby alleviating pain. Additionally, Zoetis launched Apoquel Chewable, the first chewable medication for managing allergic itch and inflammation in dogs aged one year or older. Librela represents a significant advancement in veterinary pain management, offering a new approach to treating chronic pain in dogs.

In January 2024, Ceva Sante Animale, a France-based provider of animal health products and services, acquired Scout Bio Inc. for an undisclosed amount. This acquisition is intended to boost Ceva Sante's global biotechnology initiatives in animal health by leveraging Scout Bio's expertise in advanced therapies, such as gene therapy and monoclonal antibodies. Scout Bio Inc., a US-based biotechnology firm, is known for developing a pipeline of monoclonal antibody therapies aimed at treating chronic conditions in pets.

Major companies operating in the monoclonal antibodies in veterinary health market are Sanofi S.A., Bristol-Myers Squibb Company, GlaxoSmithKline plc (GSK), Amgen Inc., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Zoetis Inc., MSD Animal Health, Elanco Animal Health Incorporated, Bio-Rad Laboratories Inc., Eli Lilly and Company, GenScript Biotech Corporation, Abcam plc, Heska Corporation, Neogen Corporation, iNova Pharmaceuticals, Ceva Sante Animale S.A., Biogenesis Bago S.A., TransGen Biotech Co. Ltd., AbCellera Biologics Inc., Areteia Therapeutics Inc., Esco Aster Pte Ltd, PetMedix Ltd., Vaxine Pty Ltd

North America was the largest region in the monoclonal antibodies in veterinary health market in 2024. The regions covered in the monoclonal antibodies in veterinary health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the monoclonal antibodies in veterinary health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The monoclonal antibodies in veterinary health market consist of sales of diagnostic kits, therapeutic drugs, research reagents, monoclonal antibody drugs, and therapeutic formulations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Monoclonal Antibodies In Veterinary Health Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on monoclonal antibodies in veterinary health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for monoclonal antibodies in veterinary health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The monoclonal antibodies in veterinary health market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Animal Type: Dogs; Other Animal Types
• 2) By Application: Dermatology; Pain; Other Applications
• 3) By End-User: Veterinary Hospitals; Other End-Users
• Subsegments:
• 1) By Dogs: Canine Infectious Diseases; Canine Cancer Treatment; Canine Autoimmune Disorders; Canine Allergies
• 2) By Other Animal Types: Cats; Horses; Cattle; Swine; Poultry; Aquatic Animals; Small Mammals
• Companies Mentioned: Sanofi S.A.; Bristol-Myers Squibb Company; GlaxoSmithKline plc (GSK); Amgen Inc.; Boehringer Ingelheim International GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Monoclonal Antibodies In Veterinary Health Market Characteristics

3. Monoclonal Antibodies In Veterinary Health Market Trends And Strategies

4. Monoclonal Antibodies In Veterinary Health Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Monoclonal Antibodies In Veterinary Health Growth Analysis And Strategic Analysis Framework

• 5.1. Global Monoclonal Antibodies In Veterinary Health PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Monoclonal Antibodies In Veterinary Health Market Growth Rate Analysis
• 5.4. Global Monoclonal Antibodies In Veterinary Health Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Monoclonal Antibodies In Veterinary Health Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Monoclonal Antibodies In Veterinary Health Total Addressable Market (TAM)

6. Monoclonal Antibodies In Veterinary Health Market Segmentation

• 6.1. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dogs
• Other Animal Types
• 6.2. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dermatology
• Pain
• Other Applications
• 6.3. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospitals
• Other End-Users
• 6.4. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Dogs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Canine Infectious Diseases
• Canine Cancer Treatment
• Canine Autoimmune Disorders
• Canine Allergies
• 6.5. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Other Animal Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cats
• Horses
• Cattle
• Swine
• Poultry
• Aquatic Animals
• Small Mammals

7. Monoclonal Antibodies In Veterinary Health Market Regional And Country Analysis

• 7.1. Global Monoclonal Antibodies In Veterinary Health Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Monoclonal Antibodies In Veterinary Health Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market

• 8.1. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Monoclonal Antibodies In Veterinary Health Market

• 9.1. China Monoclonal Antibodies In Veterinary Health Market Overview
• 9.2. China Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Monoclonal Antibodies In Veterinary Health Market

• 10.1. India Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Monoclonal Antibodies In Veterinary Health Market

• 11.1. Japan Monoclonal Antibodies In Veterinary Health Market Overview
• 11.2. Japan Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Monoclonal Antibodies In Veterinary Health Market

• 12.1. Australia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Monoclonal Antibodies In Veterinary Health Market

• 13.1. Indonesia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Monoclonal Antibodies In Veterinary Health Market

• 14.1. South Korea Monoclonal Antibodies In Veterinary Health Market Overview
• 14.2. South Korea Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Monoclonal Antibodies In Veterinary Health Market

• 15.1. Western Europe Monoclonal Antibodies In Veterinary Health Market Overview
• 15.2. Western Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Monoclonal Antibodies In Veterinary Health Market

• 16.1. UK Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Monoclonal Antibodies In Veterinary Health Market

• 17.1. Germany Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Monoclonal Antibodies In Veterinary Health Market

• 18.1. France Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Monoclonal Antibodies In Veterinary Health Market

• 19.1. Italy Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Monoclonal Antibodies In Veterinary Health Market

• 20.1. Spain Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Monoclonal Antibodies In Veterinary Health Market

• 21.1. Eastern Europe Monoclonal Antibodies In Veterinary Health Market Overview
• 21.2. Eastern Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Monoclonal Antibodies In Veterinary Health Market

• 22.1. Russia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Monoclonal Antibodies In Veterinary Health Market

• 23.1. North America Monoclonal Antibodies In Veterinary Health Market Overview
• 23.2. North America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Monoclonal Antibodies In Veterinary Health Market

• 24.1. USA Monoclonal Antibodies In Veterinary Health Market Overview
• 24.2. USA Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Monoclonal Antibodies In Veterinary Health Market

• 25.1. Canada Monoclonal Antibodies In Veterinary Health Market Overview
• 25.2. Canada Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Monoclonal Antibodies In Veterinary Health Market

• 26.1. South America Monoclonal Antibodies In Veterinary Health Market Overview
• 26.2. South America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Monoclonal Antibodies In Veterinary Health Market

• 27.1. Brazil Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Monoclonal Antibodies In Veterinary Health Market

• 28.1. Middle East Monoclonal Antibodies In Veterinary Health Market Overview
• 28.2. Middle East Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Monoclonal Antibodies In Veterinary Health Market

• 29.1. Africa Monoclonal Antibodies In Veterinary Health Market Overview
• 29.2. Africa Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Monoclonal Antibodies In Veterinary Health Market Competitive Landscape And Company Profiles

• 30.1. Monoclonal Antibodies In Veterinary Health Market Competitive Landscape
• 30.2. Monoclonal Antibodies In Veterinary Health Market Company Profiles
  • 30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline plc (GSK) Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Monoclonal Antibodies In Veterinary Health Market Other Major And Innovative Companies

• 31.1. Regeneron Pharmaceuticals Inc.
• 31.2. Zoetis Inc.
• 31.3. MSD Animal Health
• 31.4. Elanco Animal Health Incorporated
• 31.5. Bio-Rad Laboratories Inc.
• 31.6. Eli Lilly and Company
• 31.7. GenScript Biotech Corporation
• 31.8. Abcam plc
• 31.9. Heska Corporation
• 31.10. Neogen Corporation
• 31.11. iNova Pharmaceuticals
• 31.12. Ceva Sante Animale S.A.
• 31.13. Biogenesis Bago S.A.
• 31.14. TransGen Biotech Co. Ltd.
• 31.15. AbCellera Biologics Inc.

32. Global Monoclonal Antibodies In Veterinary Health Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Monoclonal Antibodies In Veterinary Health Market

34. Recent Developments In The Monoclonal Antibodies In Veterinary Health Market

35. Monoclonal Antibodies In Veterinary Health Market High Potential Countries, Segments and Strategies

• 35.1 Monoclonal Antibodies In Veterinary Health Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Monoclonal Antibodies In Veterinary Health Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Monoclonal Antibodies In Veterinary Health Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33505_Monoclonal_Antibodies_In_Veterinary_Health_GMR_2025